chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme soreness at injection site when moving muscle, joint pain,  extreme aches, tiredness, fever
PATIENT TOLD US HER DOCTOR SAID SHE HAS A MILD CASE OF GULLAIN-BARRE SYNDROME.  STARTED AS A PARTIAL PARALYSIS OF LEGS.
FEVER; This spontaneous report received from a patient via a company representative concerned a 36 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 04:15 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever. This report was non-serious.
This spontaneous case reported by a consumer, describes the occurrence of pain (swollen painful lymph nodes, archness), lymphadenopathy, lymph node pain and headache in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 21, 2022, patient received the third (booster) dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. In January 2022, patient experienced pain (swollen painful lymph nodes, archness), lymphadenopathy, lymph node pain and headache. At the time of the report, pain (swollen painful lymph nodes, archness), lymphadenopathy, lymph node pain and headache: not resolved. No concomitant and treatment medications reported. After 5-6 days of receiving the booster, patient had a headache.
I had a episode of atrial flutter.  It was treated over the course of two days at Hospital.  I was admitted on the 14JUN2023 my symtoms began 13JUN2023 wirth a high heart rate, it was lowered on the 14JUN2023  but was elevated again on 15JUN2023 and was brought back into rythym with electric shock at the hospital on 15JUN2023 and I was released from th hospital.
Patient received Tdap on 08/15/22. Patient then received TD on 08/19/22.
This spontaneous report was received from a female consumer concerning her 1 year son, who on an unknown date in 2012, was vaccinated with a dose of MMR II (route, lot number and expiration date were not provided). No other co-suspects were reported. No concomitant medications were reported. The consumer stated that about month ago, in approximately August 2012, her son had developed thrombocytopenia shortly after turning 1 year old. The consumer could not verify if the patient had received the vaccine or not at 12 months old. The consumer stated that she was reading the product insert and noticed what it said about getting developing thrombocytopenia after getting the vaccination, and she realized that the patient might have received the vaccine shortly after developing thrombocytopenia. The patient was given unspecified IV infusion as treatment for the event. On an unknown date, the patient improved. Additional information is not expected.
1cm x 1cm firm mobile mass on rt deltoid w/darkish discoloration;
Received injections 11/20/2003 around 13:00.  Noticed redness, blisters and swelling evening of 11/21/2003.  Taken to ER 11/22/2003.  Given antibiotic and Benadryl.
Heavy sweating; Tenderness; Swelling in his armpit; Headaches; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), HYPERHIDROSIS (Heavy sweating), TENDERNESS (Tenderness), SWELLING (Swelling in his armpit) and HEADACHE (Headaches) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), LOSARTAN POTASSIUM (COZARIL), SERTRALINE HYDROCHLORIDE (ZOLOFT) and OMEPRAZOLE SODIUM (OMEPRAZOLE [OMEPRAZOLE SODIUM]) for an unknown indication.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Body aches), HEADACHE (Headaches) and CHILLS (Chills). On 03-Mar-2021, the patient experienced HYPERHIDROSIS (Heavy sweating), TENDERNESS (Tenderness) and SWELLING (Swelling in his armpit). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), HYPERHIDROSIS (Heavy sweating), TENDERNESS (Tenderness), SWELLING (Swelling in his armpit), HEADACHE (Headaches) and CHILLS (Chills) outcome was unknown.            Other relevant concomitant medications included: Diabetes med, Blood pressure med and Supplements.
No initial reaction. After about 10 days, injection site turned red, with slight swelling. Over the next few days, the area expanded. after four days, the area is about the size of my hand, and feels warm to the touch. There is no pain, nor itching. Thee are no other symptoms - fever, etc. Patient has not contact the clinic where the vaccine was administered, or his physician.
Information has been received from 2 healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 28-APR-2015, the patient was received improperly stored (Oka/Merck) VARIVAX (lot # K026385, exp date 15-DEC-2016, dose and route unknown). Concomitant medication was not reported. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
pt recvd vax; rash p. 3rd & 4th doses; 25jan94 recvd 5th dose uneventful
She got her vaccine, started with a headache and neck pain.  By that evening her shoulders were heavy and was hurting in her back, side, down her legs, all the way to her toes.  Her body felt like she was frozen in place, achy all over, felt like the flu as her muscles were aching.  She went to bed early that night.  The next morning she wasn't having any pain but had some post nasal drip and was wheezing.  She used her inhaler, and as the day went on the headache would come and go and it was in the back of her head down to her  neck, and had to use her inhaler often.  She then started with coughing and sneezing, which would not stop.  She thought was better last night, but she felt that the inhaler helped her to feel better.  She woke up this morning with a pounding headache and pain in her neck, and is also wheezing.    The vaccine seems to have triggered her asthma, and has not had any difficulty or reactions with the other vaccines.  She is having to use her Albuterol inhaler frequently.
SICKNESS; PAIN; NIGHTMARES; This spontaneous report received from a patient concerned a 40 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced pain. On APR-2021, the subject experienced nightmares. Laboratory data included: Diagnostic ultrasound (NR: not provided) ultrasound of leg showed subject was not sick. On 08-APR-2021, the subject experienced sickness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pain, nightmares and sickness was not reported. This report was non-serious.
pt recv vax 13NOV97 & 14NOV97 pt seen in urgent care w/ c/o lt arm swollen, red;placed on motrin & Keflex r/o infect;15NOV97 seen in peds lt arm red, hot, swollen, painful & itchy;dx adverse vax rxn;
This spontaneous report as received from a 35 year old male patient reporting himself. The patient's medical history included serious car accident, surgery (not specified) and no known allergies. On 21-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX at a pharmacy (lot number, expiry date, dose and route unspecified). Concomitant therapies included acetaminophen, NORCO, meloxicam, SOMA, KLONOPIN and gabapentin. On 21-OCT-2013, the patient experienced redness, pain and malaise after receiving the ZOSTAVAX. The patient had not sought medical attention. The outcome of adverse events was unknown. The causality between adverse events and ZOSTAVAX was not provided. Additional information has been requested.
Patient developed blurred vision Rt eye. His eyelid became swollen and eye very red. He has severe pain. On 10/15/11 ophthalmologist stated he had virus. We mention Flu shot. She couldn't give an answer. Presently eye problem/now cold and pain Rt ear.
On 04/13/2021 around 4:00 PM, I started with a pretty strong headache.  As the night went on, in addition to the headache, nausea started around 6:00 PM.  Around 7:00 PM, chills started.  Waking up on 04/14/2021, I still have a very mild headache but no other symptoms.  My arm has been mildly sore since receiving the shot on 04/12/2021.
Information has been received from a registered nurse concerning a 12 month old female who on 02/15/2005 was vaccinated with a dose of varicella virus vaccine live.  On 02/23/2005 the patient developed a fever of 101.7 degrees with emesis.  Over the following 48 hours, the patient developed a moderate varicella rash.  The patient was treated with acetaminophen and calamine lotion.  Unspecified medical attention was sought.  The outcome was reported as recovering.  There was no product quality complaint.  Additional information has been requested.
Patient allergic to everything, after 20 minutes reports feeling itching on arm. Situation was evaluated and she will go to emergency.
By parent report fever and wheezing began 1-2 hrs after visit and reception of immunizations. Seen for return visit 10/03/06, wheezing but afebrile nebulizer treatment with Albuterol cleared wheezing.
Started having difficulty walking up stairs and inclines in August 2021, then began to have issues walking.  Began using a cane in September but had a few falls so graduated to a walker in November.  Moved to a wheelchair in January 2022 and can now no longer walk or stand - am completely reliant on the wheelchair to move.  Am still able to transfer as my arms still have strength.
pt said her tongue started swelling and became very prickly about 15 minutes after getting the vaccine.   This reaction would come and go for seven days straight.  The symptoms were be less severe with each episode.
On 8/1/06 in the afternoon pt has slight swelling at site.  Progressed - swollen from shoulder to elbow.  Some lethargy, poor appetite.  Seen by Dr. 8/3/06 - recommended no TD for 10 years.
Pt states she immediately did not feel "right" after shot. Went to class to teach. 1 hour 45 min after injection, throat scratchy, dried. BP 150/90, skin read and blotchy. Pinna of both ears became red and waxy in appearance. 50mg BENADRYL po, 0.3mg EPI given L arm SC. EMS called to Hosp via ambulance @ 200pm.
After about ten minutes, patient indicated she wasn't feeling right.  She described "a funny feeling around (her) eyes."  There was no apparent swelling or dizziness and no other signs of reaction.  I took her blood pressure and it was 198/101 mmHg.  She thought maybe it shot up because she was nervous, but that she has a history of high blood pressure.  After about 5 minutes we rechecked it and it came down to 168/98.  We waited 5 more minutes and rechecked again.  It was 175/92.  Her pulse was between 72-77 each time.  She waited for a total of a half hour and had no other symptoms.  She had a doctors appointment tomorrow and said she would address it with them at that time.
This is a spontaneous report from a contactable consumer (patient). A 38-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3247) via an unspecified route of administration (age at the time of vaccination was 38 years and non-pregnant at the time of vaccination) on 17Feb2021 09: 15 AM in left arm as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history was none. Concomitant medication was not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3247), via an unspecified route of administration (age at the time of vaccination was 38 years and non-pregnant at the time of vaccination) on 27Jan2021 09: 00 AM in left arm as DOSE 1, SINGLE for COVID-19 immunisation. There were no other vaccine in four weeks. There were no other medications in two weeks. There was no covid prior vaccination. Not tested for COVID post vaccination. There were no known allergies. On 17Feb2021 at 08:00 PM, the patient had chills, fever, body aches, headaches and soreness of arm. The patient did not receive any treatment for the events. The outcome of the events was reported as recovering. Follow-up attempts completed. No further information expected.
This case was reported by a physician via sales rep and described the occurrence of skin red in a adult female patient who received FLULAVAL QUADRIVALENT. Concurrent medical conditions included drug allergy. Concomitant products included Losartan, XYZAL, COQ10, Red Rice Yeast Extract, SYNTHROID and glucosamine. On 12th September 2017, the patient received FLULAVAL QUADRIVALENT. On 12th September 2017, less than a day after receiving FLULAVAL QUADRIVALENT, the patient experienced skin red, injection site itching, blister and photosensitivity. On 17th September 2017, the outcome of the skin red, injection site itching, blister and photosensitivity were recovered/resolved. The reporter considered the skin red, injection site itching and blister to be related to FLULAVAL QUADRIVALENT. It was unknown if the reporter considered the photosensitivity to be related to FLULAVAL QUADRIVALENT. Additional details were reported as follows: The age at vaccination was not reported. At the injection site, the patient's skin was itchy. The patient was exposed to the sun on the same day and had photosensitivity. The patient experienced redness on the face, neck and chest. Between the 12th September 2017 and 17th September 2017, when the patient had redness of the skin, she also developed blisters on her ears and neck. The physician gave consent to reach out to her office manager, if she was to be contacted.
weak, dizzy, headache, chills, fever, sleepy, sore throat, and sweaty towards the end.
Immediately after patient received 3 shots, I nursed him for comfort. About 5 minutes after, I went to dress him and saw the skin where 1 shot was given was very red and the redness was spreading outward from band aid. I called Dr to take a look. She removed the band aid and there was one hive at the injection site. It was about the size of an M&M candy. She listened to his heart and respiration and gave him 3.75 ml of Benadryl. Patient seemed fine and the hive was gone that evening.
Vaccine given 5:30 pm 1/10. Patient experienced arrhythmias the following morning. She already is treated for this with beta blockers but has been symptom free. She was monitored by her physician & he eventually directed her to ER on 1/13.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 53-year-old male patient who received Shingrix for prophylaxis. On 13th September 2018, the patient received Shingrix (intramuscular). On 14th September 2018, 1 days after receiving Shingrix, the patient experienced injection site pain. On 17th September 2018, the patient experienced feeling cold, shivering and tiredness. On 18th September 2018, the patient experienced headache. On 17th September 2018, the outcome of the feeling cold, shivering and tiredness were recovered/resolved. On an unknown date, the outcome of the injection site pain and headache were recovering/resolving. It was unknown if the reporter considered the injection site pain, feeling cold, shivering, tiredness and headache to be related to Shingrix. Additional information received as follows: At 2:00 pm, the patient received Shingrix on the left deltoid. At night, while driving home the patient began to felt tired and he went to bed. The patient experienced intense shivering and a cold feeling which he described as chills with violent shivering. The symptoms lasted for two hours and he went to sleep. On the reporting day, he continued to have a dull headache. The contact details of the physician were provided.
Left hand including the wrist was completely non functioning upon waking up this morning.  Left hand was completely limp. Had to use my right hand to move my left hand. The experience was comparable to what is described as "falling asleep" , the exception is that there was no tingling sensation. This lasted for approximately 5 minutes. Upon getting out of bed this followed by approx. 2-3 minutes of light headedness. Joints in both elbows and wrists are sore, more so on the left side.
injection felt hot and swollen for 2 weeks; injection felt hot and swollen for 2 weeks; fatigue; chills/chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection felt hot and swollen for 2 weeks), VACCINATION SITE SWELLING (injection felt hot and swollen for 2 weeks), FATIGUE (fatigue) and CHILLS (chills/chills) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     Concomitant products included METFORMIN HYDROCHLORIDE (METFORMIN [METFORMIN HYDROCHLORIDE]), INSULIN ASPART (NOVOLOG) and LISINOPRIL for an unknown indication.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced VACCINATION SITE WARMTH (injection felt hot and swollen for 2 weeks), VACCINATION SITE SWELLING (injection felt hot and swollen for 2 weeks), FATIGUE (fatigue) and CHILLS (chills/chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 800 milligram. On 26-Aug-2021, FATIGUE (fatigue) and CHILLS (chills/chills) had resolved. In September 2021, VACCINATION SITE WARMTH (injection felt hot and swollen for 2 weeks) and VACCINATION SITE SWELLING (injection felt hot and swollen for 2 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This non-serious initial spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult, male patient of unspecified age. This refers to 84 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 and there were no reports of adverse effect after vaccination (not adverse effect). The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly. Non-significant follow up received on 27-Nov-2017 from a physician: Date of birth of the patient was updated.
Four 16 year old patients received both Moderna Covid-19 Vaccines; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four 16 year old patients received both Moderna Covid-19 Vaccines) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four 16 year old patients received both Moderna Covid-19 Vaccines). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Four 16 year old patients received both Moderna Covid-19 Vaccines) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age was recorded as received from health authority. Unable to clarify or confirm.   Reporter did not allow further contact
The patient came in to pharmacy for a Shingrix vaccination, he received a Covid19 vaccination.
Information has been received from a physician concerning an infant with a hepatitis B positive mother who was vaccinated with a first, second, and third dose of haemophilus B conjugate vaccine (+) hepatitis B vaccine recombinant (yeast) at birth, one month, and 6 months. At 10-11 months, the physician took two different titers, and the patient had no protection. Additional information has been requested.
Client received the 2nd dose of Pfizer COVID vaccine lot #EW0167 and expiration date  at 2:22pm.  Client reports to vaccinator RN, that he feels dizzy. RN immediately offered client a bottle of water.  PHN walked over to client sitting upright in chair alert and oriented x4 at 2:23PM.  Client reports feeling "foggy and confused".  Client also reports not drinking a lot of water today. At 2:31pm client reports dizziness feels "better after drinking on bottle of water."  Client reports medical history includes that he is bipolar and later reports he has a history of vertigo. Vitals at 2:33PM:  blood pressure:130/75, oxygen: 98% and pulse87 and "feels a little clearer, less foggy".  At 2:38pm, vitals: blood pressure:120/75, oxygen: 98% and pulse:83 client reports he is still a "little dizzy".  PHN gave client ER precautions and to report to provider.  At 2:43pm vitals: blood pressure: 115/75, pulse:83 and oxygen:98%. client reports "slight dizziness" and that he is hungry and that fogginess is gone. At 2:48pm vitals : blood pressure:115/80, oxygen:98%, and pulse: 79.  At 2:51pm, client reports dizziness is gone.  At 2:53pm vitals: blood pressure: 115/80, oxygen:98% and pulse:80.  At 2:55pm text lead PHN that after client felt better he reports feeling slight dizziness. PHN comes to check client.  Client reports to PHN he feels good enough to drive and PHN advises if he is dizzy it is best to get a ride. At 2:58PM client left facility with a steady gait.
On 9/8/10 I got my pneumonia shot, that evening I had extreme difficulty in moving my arm. During the night I became dizzy and nauseous and extremely hot. The following day my arm became hot and swollen that evening I went to urgent care. I was treated with steroids and antibiotics.